Key result
Propranolol prolonged time to fibrillation during transient ischaemia from 122 to 262 seconds by attenuating tachycardia, but lacked protective effect during prolonged ischaemia.
Why the study?
Does propranolol prevent ischaemic ventricular fibrillation in a pig model of ischaemia?
Does propranolol prevent ischaemic ventricular fibrillation in a pig model of ischaemia?
Propranolol prevents ischaemic ventricular fibrillation in a pig model primarily through its heart rate-lowering effect, but does not offer effective protection independent of heart rate control during the first hour of infarction.
Answers are grounded in this paper and cite their sources.
Supports rate-dependent VF delay in transient ischaemia models; leaves open independent effects during prolonged infarction.
OBJECTIVES: To investigate the prevention of ventricular fibrillation with a beta-adrenergic receptor (beta-AR) antagonist in anaesthetized, open-chest pigs in a model of ischaemia, intended to reproduce what happens either in anginal attack or in the first hour of infarction. METHODS: Ventricular fibrillation threshold (VFT) was determined with trains of diastolic stimuli of 100 ms duration delivered by a subepicardial electrode inserted in the area subjected to ischaemia. Ischaemia was obtained by the complete occlusion of the left anterior descending coronary artery, either near its origin during brief but increasing periods (30, 60, 90, 120, 150, 180, 240, 300 s), or half-way from its origin for a much longer time (more than 60 min). RESULTS: During transient proximal occlusion and isoprenaline infusion (0.25 microgram/kg/min), propranolol (50 micrograms/kg plus 2 micrograms/kg/min) attenuated both tachycardia and the fall in VFT to 0 mA. The shortening of MAP duration accompanying depolarization of the fibres was concurrently slowed down, and time to fibrillation prolonged (122 +/- 15 to 262 +/- 14 s, p < 0.001). In the absence of isoprenaline infusion, propranolol exerted similar effects, but to a lesser degree, in proportion to heart rate dependent on sympathetic activity. In contrast, it became unable to raise VFT before and during ischaemia, when heart rate was kept constant by pacing. After persistent midportion occlusion, significant differences in VFT were found only at the 5th min, depending on whether heart rate was accelerated by isoprenaline (0.8 +/- 0.2 mA), left normal (1.8 +/- 0.3 mA) or slowed down by propranolol (1.6 +/- 0.3 mA). Later on, especially after 15 and 25 min of ischaemia, VFT, which was below 1.0 mA, did not appear to be influenced by the activation or blockade of beta-ARs: spontaneous fibrillations were observed in the same number in this period with or without the administration of propranolol. Beyond 30 min after occlusion, the rise in VFT, subsequent to the first irreversible cell damage, also occurred in the same way. CONCLUSIONS: The prevention of ischaemic ventricular fibrillation by a beta-AR antagonist, judged from VFT, is easily checked experimentally when ischaemia is only transitory, especially if sympathetic activity is high. The maintenance of VFT at a relatively high level is essentially related to the depressant effect on the sinus rate. The same animal model does not give support to an effective protection in the first hour of infarction. However, the control of heart rate may also be beneficial in these circumstances by attenuating systemic haemodynamic disorders.
No takes yet. Share an insight, caveat, or question.
J.-F. Aupetit (1998) studied ischaemic ventricular fibrillation. propranolol vs. control / isoprenaline was evaluated on Time to fibrillation (p=< 0.001). Propranolol prolonged time to fibrillation during transient ischaemia from 122 to 262 seconds by attenuating tachycardia, but lacked protective effect during prolonged ischaemia.
Synapse has enriched 10 related papers. Consider them for comparative context: